| |
| |
|
| Insider
Information: |
Nicholson C. David |
| Relationship: |
EVP Chief R&D Officer |
| City: |
Dublin |
| State: |
L2 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Allergan plc |
AGN |
EVP Chief R&D Officer |
2020-05-08 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGN |
Allergan plc |
EVP Chief R&D Officer |
• – – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,201) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
EVP Chief R&D Officer |
• – – |
2020-05-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,999) |
0 |
0 |
- |
|
| AGN |
Allergan plc |
EVP Chief R&D Officer |
• – – |
2020-03-02 |
4 |
A |
$193.84 |
$4,199,931 |
D/D |
21,667 |
35,972 |
0 |
- |
|
| AGN |
Allergan plc |
EVP Chief R&D Officer |
• – – |
2019-12-31 |
4 |
D |
$191.17 |
$197,096 |
D/D |
(1,031) |
14,305 |
0 |
- |
|
| AGN |
Allergan plc |
EVP Chief R&D Officer |
• – – |
2019-04-03 |
4 |
D |
$145.71 |
$126,913 |
D/D |
(871) |
15,336 |
0 |
- |
|
| AGN |
Allergan plc |
EVP Chief R&D Officer |
• – – |
2018-12-31 |
4 |
D |
$133.66 |
$153,709 |
D/D |
(1,150) |
16,207 |
0 |
- |
|
| AGN |
Allergan plc |
Chief R&D Officer |
• – – |
2018-04-03 |
4 |
D |
$164.74 |
$143,489 |
D/D |
(871) |
17,357 |
0 |
- |
|
| AGN |
Allergan plc |
Chief R&D Officer |
• – – |
2017-12-29 |
4 |
D |
$163.58 |
$177,648 |
D/D |
(1,086) |
18,228 |
0 |
- |
|
| AGN |
Allergan plc |
Chief R&D Officer |
• – – |
2017-10-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,274 |
19,314 |
0 |
- |
|
| AGN |
Allergan plc |
Chief R&D Officer |
• – – |
2017-08-04 |
4 |
D |
$242.65 |
$945,850 |
D/D |
(3,898) |
13,040 |
0 |
- |
|
| AGN |
Allergan plc |
Chief R&D Officer |
• – – |
2017-04-03 |
4 |
A |
$237.68 |
$2,099,903 |
D/D |
8,835 |
16,938 |
0 |
- |
|
| AGN |
Allergan plc |
Chief R&D OfficerOfficer |
• – – |
2016-05-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,103 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
